skip to main content

Highly sensitive epigenomic technology combats disease

Left to right, Bohan Zhu, Yuan-Pang Hsieh, and Chang Lu
Left to right, Bohan Zhu, Yuan-Pang Hsieh, and Chang Lu.

November 25th, 2019

Much remains unknown about diseases and the way our bodies respond to them, in part because the human genome is the complete DNA assembly that makes each person unique. A Virginia Tech professor and his team of researchers have created new technology to help in understanding how the human body battles diseases.

In a recently published article in Nature Protocols, Chang Lu, the Fred W. Bull Professor of Chemical Engineering at Virginia Tech, along with chemical engineering doctoral students Bohan Zhu and Yuan-Pang Hsieh, describe a microfluidic technology they are using to study a variety of diseases ranging from breast and brain cancer to schizophrenia and addiction.

 

Research Article

VT News Article

Tags